Publications


Heterotrimeric complex of p38 MAPK, PKCd, and TIRAP is required for AP1 mediated inflammatory response;
Baig, MS, Liu, D, Muthu, K, Roy, A, Saqib, U, Naim, A, Faisal, SM, Srivastava, M & Saluja, R 2017, International Immunopharmacology, vol 48, pp. 211-218. DOI:

Erratum to Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV;
Liu, D, Tian, S, Zhang, K, Xiong, W, Lubaki, NM, Chen, Z & Han, W 2017, Protein and Cell, pp. 1. DOI:

Histone demethylases UTX and JMJD3 are required for NKT cell development in mice;
Northrup, D, Yagi, R, Cui, K, Proctor, WR, Wang, C, Placek, K, Pohl, LR, Wang, R, Ge, K, Zhu, J & Zhao, K 2017, Cell and Bioscience, vol 7, no. 1, 25. DOI:

Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV;
Liu, D, Tian, S, Zhang, K, Xiong, W, Lubaki, NM, Chen, Z & Han, W 2017, Protein and Cell, pp. 1-17. DOI:

FOSL1 inhibits type i interferon responses to malaria and viral infections by blocking TBK1 and TRAF3/ TRIF interactions;
Cai, B, Wu, J, Yu, X, Su, XZ & Wang, RF 2017, mBio, vol 8, no. 1, e02161-16. DOI:

A special issue on cancer immunotherapy;
Wang, RF 2017, Cell Research, vol 27, no. 1, pp. 1-2. DOI:

The TLR4–NOS1–AP1 signaling axis regulates macrophage polarization;
Srivastava, M, Saqib, U, Naim, A, Roy, A, Liu, D, Bhatnagar, D, Ravinder, R & Baig, MS 2016, Inflammation Research, pp. 1-12. DOI:

Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality;
Yu, X, Cai, B, Wang, M, Tan, P, Ding, X, Wu, J, Li, J, Li, Q, Liu, P, Xing, C, Wang, HY, Su, XZ & Wang, RF 2016, Immunity, vol 45, no. 5, pp. 1093-1107. DOI:

Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways;
Roy, A, Srivastava, M, Saqib, U, Liu, D, Faisal, SM, Sugathan, S, Bishnoi, S & Baig, MS 2016, International Immunopharmacology, vol 40, pp. 79-89. DOI:

USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination through NLRP4 Signalosome;
Lin, M, Zhao, Z, Yang, Z, Meng, Q, Tan, P, Xie, W, Qin, Y, Wang, RF & Cui, J 2016, Molecular Cell, vol 64, no. 2, pp. 267-281. DOI: